Paper4584153
Kinetics of warfarin absorption in man.
Breckenridge A and 1 other. Clin Pharmacol Ther, 1973. Cited by 74 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Kinetics of warfarin absorption in man. Papers, record 4584153. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4584153
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Warfarin | Major topic |
| Administration, Oral | |
| Adult | |
| Aged | |
| Carbon Radioisotopes | |
| Clinical Trials as Topic | |
| Humans | |
| Injections, Intravenous | |
| Intestinal Absorption | |
| Kinetics | |
| Middle Aged | |
| Time Factors |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,647,228 | Warfarin-Induced Developmental Toxicity: Insights into Embryogenesis, Teratogenicity, and Molecular Pathways. | J Dev Biol | 2026 | https://conductscience.org/library/papers/42647228 | PubMed |
| 35,138,605 | Effects and Mechanism of Action of Panax notoginseng Saponins on the Pharmacokinetics of Warfarin. | Eur J Drug Metab Pharmacokinet | 2022 | https://conductscience.org/library/papers/35138605 | PubMed |
| 28,665,355 | In Silico Prediction for Intestinal Absorption and Brain Penetration of Chemical Pesticides in Humans. | Int J Environ Res Public Health | 2017 | https://conductscience.org/library/papers/28665355 | PubMed |
| 28,379,643 | Integrating In Vitro, Modeling, and In Vivo Approaches to Investigate Warfarin Bioequivalence. | CPT Pharmacometrics Syst Pharmacol | 2017 | https://conductscience.org/library/papers/28379643 | PubMed |
| 23,208,322 | Influence of ORM1 polymorphisms on the maintenance stable warfarin dosage. | Eur J Clin Pharmacol | 2013 | https://conductscience.org/library/papers/23208322 | PubMed |
| 22,924,488 | Predicted metabolic drug clearance with increasing adult age. | Br J Clin Pharmacol | 2013 | https://conductscience.org/library/papers/22924488 | PubMed |
| 21,279,098 | Anticoagulant therapy. | Can Fam Physician | 1984 | https://conductscience.org/library/papers/21279098 | PubMed |
| 11,496,940 | Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarin. | Pharm Res | 2001 | https://conductscience.org/library/papers/11496940 | PubMed |
| 9,068,929 | Pharmacokinetic optimisation of the treatment of deep vein thrombosis. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9068929 | PubMed |
| 8,983,860 | Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8983860 | PubMed |
| 8,527,280 | The influence of age, liver size and enantiomer concentrations on warfarin requirements. | Br J Clin Pharmacol | 1995 | https://conductscience.org/library/papers/8527280 | PubMed |
| 7,917,775 | Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin. | Br J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7917775 | PubMed |
| 7,381,693 | Mathematical basis and generalization of the Loo-Riegelman method for the determination of in vivo drug absorption. | J Pharmacokinet Biopharm | 1980 | https://conductscience.org/library/papers/7381693 | PubMed |
| 6,690,067 | Aminoglutethimide and warfarin. A new important drug interaction. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6690067 | PubMed |
| 6,661,352 | Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6661352 | PubMed |
| 6,347,619 | Drug interactions with warfarin. | Drugs | 1983 | https://conductscience.org/library/papers/6347619 | PubMed |
| 6,329,253 | The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6329253 | PubMed |
| 4,830,225 | Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. | J Clin Invest | 1974 | https://conductscience.org/library/papers/4830225 | PubMed |
| 3,818,988 | Proposed classification of resistances to oral anticoagulant therapy. | J Clin Pathol | 1987 | https://conductscience.org/library/papers/3818988 | PubMed |
| 3,542,339 | Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship. | Clin Pharmacokinet | 1986 | https://conductscience.org/library/papers/3542339 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4584153
GET https://conductscience.org/api/papers/v1/4584153/cited_by?page=2